Optiscan Imaging Ltd (Optiscan) is a medical technology company. It focuses on the development and application of microscopic imaging technologies for medical procedures. The company provides real-time, non-invasive, slide-free digital imaging solutions. The company’s major products include fiber optic fluorescence confocal endomicroscopes, such as ViewnVivo for life sciences research and InVivage for intra-oral applications. These products are used by healthcare professionals and researchers for applications in disease detection, surgical margin assessment, and research in physiology and pathology. The company conducts clinical trials on microimaging in the fields of gastrointestinal endoscopy, and neurosurgery. It has distributors in China, Europe, North America, Asia and other countries. Optiscan is headquartered in Melbourne, Victoria, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Optiscan Imaging Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Optiscan Imaging Ltd Company Overview
- Optiscan Imaging Ltd Company Snapshot
- Optiscan Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Optiscan Imaging Ltd - Pipeline Analysis Overview
- Business Description
- Optiscan Imaging Ltd - Key Facts
- Optiscan Imaging Ltd - Major Products and Services
- Optiscan Imaging Ltd Pipeline Products by Development Stage
- Optiscan Imaging Ltd Ongoing Clinical Trials by Trial Status
- Optiscan Imaging Ltd Pipeline Products Overview
- Digital Confocal Laser Endomicroscopic Imaging System - Breast Cancer
- Digital Confocal Laser Endomicroscopic Imaging System - Breast Cancer Product Overview
- InVivage
- InVivage Product Overview
- InVivage Clinical Trial
- Laser Scanning Confocal Endomicroscope - Esophageal Cancer
- Laser Scanning Confocal Endomicroscope - Esophageal Cancer Product Overview
- Machine Learning Algorithm - Computer Assisted Diagnosis
- Machine Learning Algorithm - Computer Assisted Diagnosis Product Overview
- Machine Learning Algorithm - Telepathology
- Machine Learning Algorithm - Telepathology Product Overview
- Miniature Digital Microscopy Probe
- Miniature Digital Microscopy Probe Product Overview
- Optiscan Rigid Endoscope - Cervical Cancer
- Optiscan Rigid Endoscope - Cervical Cancer Product Overview
- Optiscan Rigid Endoscope - Endometriosis
- Optiscan Rigid Endoscope - Endometriosis Product Overview
- Optiscan Roboscope - Prostatectomy
- Optiscan Roboscope - Prostatectomy Product Overview
- Optiscan System - Breast Cancer
- Optiscan System - Breast Cancer Product Overview
- Rigid Endoscope - Liver Imaging
- Rigid Endoscope - Liver Imaging Product Overview
- Second-Generation GI Endomicroscope
- Second-Generation GI Endomicroscope Product Overview
- Optiscan Imaging Ltd - Key Competitors
- Optiscan Imaging Ltd - Key Employees
- Optiscan Imaging Ltd - Key Employee Biographies
- Optiscan Imaging Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Optiscan Imaging Ltd, Recent Developments
- Nov 04, 2024: Optiscan Signs Agreement with Monash to Progress GI Scope
- Jul 15, 2024: Optiscan Receives Ethical Clearance for Breast Cancer Study
- Jun 04, 2024: Optiscan Reveals InVue Imaging Device for Precision Surgery
- May 13, 2024: Optiscan Signs Know-How Agreement with Mayo Clinic
- Feb 13, 2024: Optiscan Receives $3 Million CRC-P Industry Grant
- May 15, 2023: Optiscan oral study published in prestigious medical journal
- Apr 03, 2023: Optiscan establishes US commercial operation in Minnesota
- Mar 14, 2023: Optiscan platform highly accurate for oral cancer diagnosis
- Aug 22, 2022: Optiscan Imaging submits FDA 510(k) application for InVivage device
- Jun 27, 2022: Optiscan Imaging announces strategic distribution partnership for China
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Optiscan Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Optiscan Imaging Ltd Pipeline Products by Equipment Type
- Optiscan Imaging Ltd Pipeline Products by Indication
- Optiscan Imaging Ltd Ongoing Clinical Trials by Trial Status
- Optiscan Imaging Ltd, Key Facts
- Optiscan Imaging Ltd, Major Products and Services
- Optiscan Imaging Ltd Number of Pipeline Products by Development Stage
- Optiscan Imaging Ltd Pipeline Products Summary by Development Stage
- Optiscan Imaging Ltd Ongoing Clinical Trials by Trial Status
- Optiscan Imaging Ltd Ongoing Clinical Trials Summary
- Digital Confocal Laser Endomicroscopic Imaging System - Breast Cancer - Product Status
- Digital Confocal Laser Endomicroscopic Imaging System - Breast Cancer - Product Description
- InVivage - Product Status
- InVivage - Product Description
- InVivage - An Oral Imaging Study of InVivage For the Diagnosis of Oral Cancer and Precancer
- Laser Scanning Confocal Endomicroscope - Esophageal Cancer - Product Status
- Laser Scanning Confocal Endomicroscope - Esophageal Cancer - Product Description
- Machine Learning Algorithm - Computer Assisted Diagnosis - Product Status
- Machine Learning Algorithm - Computer Assisted Diagnosis - Product Description
- Machine Learning Algorithm - Telepathology - Product Status
- Machine Learning Algorithm - Telepathology - Product Description
- Miniature Digital Microscopy Probe - Product Status
- Miniature Digital Microscopy Probe - Product Description
- Optiscan Rigid Endoscope - Cervical Cancer - Product Status
- Optiscan Rigid Endoscope - Cervical Cancer - Product Description
- Optiscan Rigid Endoscope - Endometriosis - Product Status
- Optiscan Rigid Endoscope - Endometriosis - Product Description
- Optiscan Roboscope - Prostatectomy - Product Status
- Optiscan Roboscope - Prostatectomy - Product Description
- Optiscan System - Breast Cancer - Product Status
- Optiscan System - Breast Cancer - Product Description
- Rigid Endoscope - Liver Imaging - Product Status
- Rigid Endoscope - Liver Imaging - Product Description
- Second-Generation GI Endomicroscope - Product Status
- Second-Generation GI Endomicroscope - Product Description
- Optiscan Imaging Ltd, Key Employees
- Optiscan Imaging Ltd, Key Employee Biographies
- Optiscan Imaging Ltd, Subsidiaries
- Glossary
- Optiscan Imaging Ltd Pipeline Products by Equipment Type
- Optiscan Imaging Ltd Pipeline Products by Development Stage
- Optiscan Imaging Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Sonic Healthcare Ltd
- RadNet Inc
- Intuitive Surgical Inc
- Thorlabs Inc
- GE Healthcare Australia Pty Ltd
- Fujifilm VisualSonics Inc
